Cybin Company Presentation

o Serial entrepreneur and investor with vast experience in the biotech and cannabis sectors. o Co-founder of Global Canna Brands which was granted the first ever tier 3 cultivation license in Jamaica. o Sold first cannabis start up TruVerra to Supreme Cannabis Company Inc. (TSX:FIRE). o Previous background in the technology industry, has advised on M&A and other financings in excess of $50M. o Co-founder and Managing Director of Trinity Venture Partners Inc., a Canadian boutique merchant bank. o A trusted advisor, he began his career practicing in the areas of corporate commercial, securities, finance and mergers and acquisitions at a leading international law firm. o Successfully raised over $70M for his multiple start-ups. o Co-founder of Growpacker Inc. o Co-Founder and Managing Director of Trinity Venture Partners Inc, a Canadian boutique merchant bank. o Co-Founder of Growpacker Inc. , a private and profitable contract manufacture of cannabis infused beverages and edibles that operates in California. o 10+ years experience in medical device and CPG manufacturing. o Early stage investor and advisor in various companies spanning multiple sectors. Management Team 24 P r i v a t e & C o n f i d e n t i a l Paul Glavine — Co-founder & CEO John Kanakis — Co-founder & SVP Business Development o 15+ years experience creating efficient scalable operations financial reporting, IFRS; regulatory reporting OSFI. o Former Ontario Securities Commission contracted Director of Finance. o Former Scotiabank senior manager of enterprise functions. o Former CFO of Global Maxfin Investments Inc. o Former CIBC small business lending controller. Authority over assets of $31B for external reporting on a monthly and quarterly basis. Eric So — Co-founder & President Grant Froese — Retail Strategist o Former Chief Operating Officer at Loblaws , Canada’s largest food and drug retailer. o 38 years experience within the retail industry. o Extensive background in merchandising, supply chain management, digital, marketing and innovative strategies. o Served on various private and public boards. o Former Director of Medical and Regulatory Affairs and Corporate Vice President at Biovail Pharmaceuticals. Former Medical Director at Eli Lilly and Company (Finland) and multiple roles as C-level officer in private biotech companies. o 25 years of pharma experience spanning multiple medical specialties, academic, clinical research regulatory affairs, preclinical, regulatory and clinical drug development from Phase I to Phase IV. o Designed and managed large number of Phase 1a and b trials, hundreds of Phase 2-3 clinical registration trials, Phase 3b and 4 trials in Europe, Asia, US and Canada. o 60 original publications in top-rated international medical journals, author of over 80 CSR's, 2 health outcome reports and 11 review articles. Jukka Karjalainen Ph.D., M.D. — Chief Medical Officer Greg Cavers — CFO

RkJQdWJsaXNoZXIy NDMyMDk=